- Home
- RAPT vs BYFC Comparison
RAPT vs BYFC Comparison
Compare RAPT & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- BYFC
- Stock Information
- Founded
- RAPT 2015
- BYFC 1946
- Country
- RAPT United States
- BYFC United States
- Employees
- RAPT N/A
- BYFC N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- BYFC Savings Institutions
- Sector
- RAPT Health Care
- BYFC Finance
- Exchange
- RAPT Nasdaq
- BYFC Nasdaq
- Market Cap
- RAPT 65.6M
- BYFC 61.4M
- IPO Year
- RAPT 2019
- BYFC 1996
- Fundamental
- Price
- RAPT $1.52
- BYFC $7.20
- Analyst Decision
- RAPT Hold
- BYFC
- Analyst Count
- RAPT 10
- BYFC 0
- Target Price
- RAPT $5.00
- BYFC N/A
- AVG Volume (30 Days)
- RAPT 920.1K
- BYFC 7.9K
- Earning Date
- RAPT 11-12-2024
- BYFC 10-29-2024
- Dividend Yield
- RAPT N/A
- BYFC N/A
- EPS Growth
- RAPT N/A
- BYFC N/A
- EPS
- RAPT N/A
- BYFC 0.26
- Revenue
- RAPT N/A
- BYFC $35,113,000.00
- Revenue This Year
- RAPT N/A
- BYFC N/A
- Revenue Next Year
- RAPT N/A
- BYFC N/A
- P/E Ratio
- RAPT N/A
- BYFC $29.05
- Revenue Growth
- RAPT N/A
- BYFC 12.14
- 52 Week Low
- RAPT $1.25
- BYFC $4.41
- 52 Week High
- RAPT $27.35
- BYFC $7.99
- Technical
- Relative Strength Index (RSI)
- RAPT 39.12
- BYFC 60.94
- Support Level
- RAPT $1.31
- BYFC $6.52
- Resistance Level
- RAPT $1.96
- BYFC $7.59
- Average True Range (ATR)
- RAPT 0.37
- BYFC 0.36
- MACD
- RAPT -0.09
- BYFC 0.06
- Stochastic Oscillator
- RAPT 10.67
- BYFC 87.18
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.